U.S. Water Utilities Stock News

NasdaqGM:PAHC
NasdaqGM:PAHCPharmaceuticals

Phibro Insider Moves Shift Class Structure As Stock Trades Near Highs

Director Jack Bendheim has sold a significant amount of NasdaqGM:PAHC stock under a pre arranged trading plan. BFI Co., LLC has converted 100,000 shares of Phibro Animal Health Class B Common Stock into Class A Common Stock. The transactions affect insider holdings, voting rights, and the mix between Class A and Class B shares in the company’s capital structure. Phibro Animal Health, listed on NasdaqGM:PAHC, focuses on animal health and nutrition products that support livestock producers...
NYSE:BAX
NYSE:BAXMedical Equipment

Baxter CFO Exit Tests Execution On Governance Reviews And Cost Discipline

Baxter International (NYSE:BAX) announced the departure of Chief Financial Officer Joel Grade, who will remain as an advisor through April 30, 2026. The Board appointed Anita Zielinski as interim CFO, effective immediately. The leadership change comes while Baxter continues its broader transition, including past governance issues, product safety reviews, and major divestitures. Baxter International operates across medical products and therapies, so stability in its finance function matters...
NYSE:WU
NYSE:WUDiversified Financial

Is It Time To Reconsider Western Union (WU) After Recent Share Price Weakness?

Wondering if Western Union at around US$9.25 is a potential bargain or a value trap? This article focuses squarely on what the current price might be implying. The stock has seen a 4.9% decline over the last 7 days and is down 3.6% over 30 days, while the 1 year return sits at a 4.4% decline and the 5 year return at a 44.9% decline. Year to date performance is close to flat at 0.2% and the 3 year return is 8.7%. Recent coverage has focused on Western Union's role as a global money transfer...
NYSE:HEI
NYSE:HEIAerospace & Defense

Is It Too Late To Consider HEICO (HEI) After The Recent Share Price Pullback?

Wondering if HEICO at around US$292.21 is still offering value, or if the best days are already priced in? This article focuses squarely on what you are paying versus what you might be getting. The share price sits near US$292.21 after a 4.6% decline over the past week and 12.1% over the last month, yet the stock has returned 12.1% over 1 year, 74.6% over 3 years and 140.9% over 5 years. Recent coverage has focused on HEICO as a key aerospace and defense name, with investors watching how...
NYSE:TNK
NYSE:TNKOil and Gas

Is Teekay Tankers’ (TNK) Zero‑Debt, Sanctions‑Exposed Model Reshaping Its Long‑Term Risk Profile?

Teekay Tankers recently reported strong 2025 operational and financial results, highlighting a zero‑debt balance sheet and significant free cash flow supported by a robust spot tanker market shaped by geopolitical tensions and sanctions-related trade shifts. The company’s gradual fleet renewal, focused on selective vessel acquisitions and sales while benefiting from heightened demand for compliant tankers, underscores how sanctions on Russian, Iranian, and Venezuelan oil are structurally...
NYSE:CFG
NYSE:CFGBanks

How Analyst Upgrades and San Francisco Commitments Could Reshape Citizens Financial Group’s (CFG) Investment Narrative

Earlier in March 2026, Citizens Financial Group received multiple analyst upgrades highlighting its loan growth, net interest margin expansion, and strong capital return, while simultaneously announcing new community and economic investment commitments in San Francisco, including US$250,000 for the San Francisco Downtown Development Corporation and US$500,000 for Main Street Launch. Together, these endorsements and local investments highlight Citizens’ attempt to pair national financial...
NYSE:NUVB
NYSE:NUVBPharmaceuticals

Nuvation Bio Cancer Data Update Tests Valuation Gap After Share Pullback

Nuvation Bio (NYSE:NUVB) presented nearly one additional year of follow up data from the TRUST-I and TRUST-II studies of IBTROZI (taletrectinib) at the AACR Annual Meeting 2026. The new data focus on long term efficacy and safety in ROS1 positive non small cell lung cancer, including both treatment naïve and previously treated patients. This update builds on IBTROZI's existing FDA approval and adds fresh clinical detail that has not been reflected in recent coverage of the company. Nuvation...
NYSE:CPNG
NYSE:CPNGMultiline Retail

Coupang (CPNG) Is Up 8.4% After Showcasing NVIDIA-Powered “AI Factory” At GTC 2026 – Has The Bull Case Changed?

Coupang recently highlighted its expanding AI capabilities at NVIDIA’s GTC 2026 in San Jose, detailing how its Coupang Intelligent Cloud and NVIDIA DGX SuperPOD form an “AI factory” to speed model development across its global e-commerce and logistics operations. The company is also backing NVIDIA as a launch partner for Dynamo, an open-source agentic inference software, underscoring how deeply integrated advanced AI is becoming in Coupang’s core logistics and delivery...
NYSE:KR
NYSE:KRConsumer Retailing

Cold Case Rollout Tests Kroger’s Premium Ice Cream And Brand Strategy

Cold Case Ice Cream is expanding into more than 1,000 Kroger banner stores across the US. The rollout brings a trend-focused premium ice cream brand to a wide range of Kroger owned banners. The move underscores Kroger's focus on differentiated product assortments in the grocery aisle. For investors watching NYSE:KR, this large scale rollout highlights how Kroger is using branded partnerships to keep its frozen aisle fresh and relevant. The company operates a broad network of supermarket...
NYSE:ATI
NYSE:ATIAerospace & Defense

Is ATI's Expanded US$500 Million Buyback a Clear Signal on Capital Priorities and EPS Focus?

ATI Inc. recently expanded its share repurchase program, with the board approving an additional US$500 million authorization that can be executed in the open market or through privately negotiated transactions without timing restrictions. This larger buyback pool, coming on top of prior repurchases that have already helped earnings per share grow faster than revenue, underscores management’s confidence in ATI’s long-term performance and capital return priorities. Next, we’ll examine how...
NasdaqGS:PDD
NasdaqGS:PDDMultiline Retail

PDD Holdings (PDD) Valuation Check As Options Volatility Climbs Before 2026 Earnings

PDD Holdings (PDD) is back in focus after options activity pointed to elevated implied volatility ahead of its March 25, 2026 earnings release, with investor attention also shaped by shifting ecommerce competition. See our latest analysis for PDD Holdings. Recent trading reflects this tension, with a 4.08% 1 month share price return contrasted against a 9.83% year to date share price decline and a 17.68% 1 year total shareholder return decline. This suggests momentum has been uneven as...
NasdaqGS:MU
NasdaqGS:MUSemiconductor

Is It Too Late To Consider Micron Technology (MU) After Its Surging Share Price?

For investors wondering whether Micron Technology at US$461.69 is priced for perfection or still offers value, this article walks through what the numbers indicate about the stock. The share price performance has been strong, with returns of 14.5% over 7 days, 12.2% over 30 days, 46.4% year to date, 355.4% over 1 year, around 7x over 3 years, and 454.1% over 5 years. These moves can change how investors think about both upside and risk. These moves are playing out against a backdrop where...
NYSE:GOLD
NYSE:GOLDRetail Distributors

Assessing Gold.com (GOLD) Valuation After Board Changes And New Commodities Expertise

Gold.com (GOLD) drew investor attention after appointing Juan Sartori to its Board of Directors and announcing the retirement of longtime director Beverley Lepine, a governance shift linked to experience in commodities and alternative assets. See our latest analysis for Gold.com. The Board change comes as Gold.com trades at a share price of $47.89, with a 46.45% 90 day share price return and a 71.11% 1 year total shareholder return. This suggests recent momentum has been strong despite a...
NasdaqGS:WGS
NasdaqGS:WGSHealthcare

A Look At GeneDx Holdings (WGS) Valuation After Ark Buying And Zevra Genetic Testing Partnership

GeneDx Holdings (WGS) is back in focus after Ark Invest’s ETFs bought shares for seven straight trading days, alongside a new Niemann Pick disease type C genetic testing collaboration with Zevra Therapeutics. See our latest analysis for GeneDx Holdings. Despite Ark’s buying streak and the new Zevra partnership, GeneDx’s share price has been under pressure, with a 30 day share price return of a 16.25% decline and a year to date share price return of a 42.93% decline, while the three year total...
NasdaqGM:EYPT
NasdaqGM:EYPTPharmaceuticals

A Look At EyePoint Pharmaceuticals (EYPT) Valuation Following Recent Mixed Share Price Performance

Recent performance snapshot EyePoint (EYPT) has drawn attention after mixed recent returns, with the share price up about 7% over the past month but showing a decline over the past 3 months and year to date. At a last close of US$13.90 and a market value of about US$1.12b, investors are weighing this performance against the company’s focus on retinal disease treatments and its developing product pipeline. See our latest analysis for EyePoint. That mix of a 7.42% 30 day share price return...
NasdaqGS:TSLA
NasdaqGS:TSLAAuto

Tesla Cybertruck Lawsuit Puts Safety And Rich Valuation Under Fresh Pressure

Tesla faces a new lawsuit in California alleging Cybertruck door electrical failures contributed to a fatal crash by trapping occupants. The case renews legal and safety scrutiny of the Cybertruck’s design and door systems. The lawsuit adds to existing questions around Tesla’s product safety and potential regulatory attention. Tesla, traded as NasdaqGS:TSLA, enters this latest legal dispute with a current share price of $399.27. The stock has seen a 77.2% return over the past year and a...
NasdaqGS:SHOP
NasdaqGS:SHOPIT

How Investors Are Reacting To Shopify (SHOP) Deepening Its Role In Localized, AI-Ready Global Commerce

In recent weeks, Transcosmos and Klaviyo announced deeper integrations with Shopify, using Shopify Plus and Shopify Markets to power localized, multi-country e-commerce and CRM experiences for brands such as Wacoal across Asia. These developments highlight how Shopify’s role as the central transaction and data layer makes it easier for global brands to standardize operations while still tailoring storefronts and marketing to each local market. We’ll now examine how Shopify’s expanding role...
NYSE:MSGE
NYSE:MSGEEntertainment

A Look At Madison Square Garden Entertainment (MSGE) Valuation After The Appointment Of New Chief Legal Officer

Madison Square Garden Entertainment (MSGE) has drawn fresh investor attention after appointing Allen Lo as Executive Vice President and Chief Legal Officer, a move that more closely connects the live entertainment group to deep technology and media legal expertise. See our latest analysis for Madison Square Garden Entertainment. The appointment of Allen Lo comes at a time when MSGE’s share price has pulled back in the short term. The 1 month share price return shows an 8% decline, but the 90...
NasdaqGS:QLYS
NasdaqGS:QLYSSoftware

Does Qualys' (QLYS) Earnings Beat Offset Questions Around Net Dollar Retention And Insider Activity?

On March 13, 2026, Qualys reported fourth-quarter 2025 results that exceeded analyst expectations, with earnings per share of US$1.87 on revenue of US$175.28 million, while Chief Legal Officer Bruce K. Posey sold 65 shares under a Rule 10b5-1 trading plan. The strong quarterly performance contrasted with analyst concerns about a softer net dollar retention rate and the absence of insider share purchases over the past year. Now we’ll consider how the strong earnings beat but softer net dollar...
NasdaqCM:LQDA
NasdaqCM:LQDAPharmaceuticals

Liquidia (LQDA) Is Down 5.1% After Q4 Profitability And New Shelf Filings - What's Changed

In March 2026, Liquidia Corporation reported fourth-quarter 2025 revenue of US$92.02 million versus US$2.92 million a year earlier, shifting from a net loss to net income of US$14.56 million and delivering positive earnings per share from continuing operations. For 2025 as a whole, revenue rose to US$158.32 million while the annual net loss narrowed to US$68.92 million, and on the same day Liquidia filed multiple shelf registrations covering common and preferred stock, debt securities,...
NYSE:TWLO
NYSE:TWLOIT

Twilio Partnerships Test Higher Value Communications Across Sports And Healthcare

Twilio (NYSE:TWLO) has signed a multi year partnership to become the exclusive cloud communications partner for the PGA of America and its championships through 2028. The company will support digital engagement for PGA members and fans, using its platform across high profile golf events and community touchpoints. Twilio is also expanding secure, branded RCS messaging into regulated industries via its collaboration with Televox (WestCX), including deployments in healthcare. Twilio enters...
NasdaqGM:CRVS
NasdaqGM:CRVSBiotechs

Is Corvus Pharmaceuticals’ Expanded US$200 Million ATM Facility Reframing Its Funding Story for CRVS?

In March 2026, Corvus Pharmaceuticals filed a universal shelf registration and expanded its at-the-market equity program with Jefferies to US$200 million, adding flexibility to issue common and preferred stock, debt, warrants and units to support ongoing operations. This expanded financing capacity sits alongside a sharp reduction in full-year 2025 net loss to US$15.28 million and continued clinical progress for lead candidate soquelitinib, together reshaping how investors may view the...
NYSE:V
NYSE:VDiversified Financial

Visa Expands Latin America Reach And Omnichannel Payments While Shares Lag Targets

Visa (NYSE:V) is expanding in Argentina through deals involving Prisma Medios de Pago and Newpay, deepening its role in local payment processing. The company has also entered a global collaboration with Ingenico to streamline payment acceptance and technology integration for merchants worldwide. These moves broaden Visa's reach in Latin America and support its push into omnichannel payments and simplified merchant onboarding. For investors watching payments infrastructure, Visa’s recent...
NYSE:MCD
NYSE:MCDHospitality

Is McDonald's New Ultra‑Low‑Price Menu Strategy Altering The Investment Case For McDonald's (MCD)?

In March 2026, McDonald’s introduced its cheapest U.S. value menu in years, adding items priced at US$3 or less and US$4 breakfast bundles to appeal to budget‑conscious diners amid economic pressures and rising beef costs. This renewed focus on aggressive value offerings highlights how McDonald’s is leaning on price perception and traffic growth, rather than premiumization alone, to reinforce its competitive position. We’ll now examine how this intensified push into ultra-low-priced meals...